GO:0003215 cardiac right ventricle morphogenesis: Development, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003215 describes the biological process by which the right cardiac ventricle is generated and organized during embryogenesis.
• The right ventricle originates from the anterior/second heart field and is added to the linear heart tube, a process distinct from left ventricle formation.
• Key transcription factors such as HEY2, TBX2, MYCN, and GATA4 regulate right ventricular morphogenesis and chamber identity.
• Disruption of right ventricle morphogenesis leads to congenital heart defects, including hypoplastic right heart syndrome and ventricular septal defects.
• Spatially organized cellular communities and lineage-specific progenitors, such as Sfrp5-negative progenitors, contribute to right ventricular myocardium.
• CRISPR-based knockout, knock-in, and overexpression models enable functional dissection of genes controlling right ventricle development.
Description
The right ventricle is a critical chamber of the heart responsible for pumping deoxygenated blood to the lungs. Its formation during embryogenesis is a complex, tightly regulated process known as cardiac right ventricle morphogenesis (GO:0003215). This process involves the specification, proliferation, and organization of cardiac progenitor cells into a functional chamber. Understanding the molecular and cellular mechanisms underlying right ventricle morphogenesis is essential for uncovering the etiology of congenital heart diseases, which affect approximately 1% of live births. Research has shown that the right ventricle is derived from distinct progenitor populations, including cells from the anterior heart field, and that its development is governed by a network of transcription factors and signaling pathways. Recent advances in single-cell and spatial transcriptomics have further revealed the heterogeneity of cell types and their spatial organization during human heart development, including the right ventricle. This article synthesizes current knowledge on GO:0003215, highlighting key genes, regulatory mechanisms, and experimental models used to study this process.
cardiac right ventricle morphogenesis At A Glance
| GO ID | GO:0003215 |
|---|---|
| GO term | cardiac right ventricle morphogenesis |
| Ontology | biological_process |
| Synonym | none |
| Major function | Generation and organization of the right cardiac ventricle |
| Related process | Heart development, cardiac chamber morphogenesis |
| Key regulators | HEY2, TBX2, MYCN, GATA4, SFRP5 |
| Disease relevance | Congenital heart defects, hypoplastic right heart syndrome |
What Is GO:0003215?
Cardiac right ventricle morphogenesis (GO:0003215) is the biological process in which the right cardiac ventricle is generated and organized. This encompasses the specification of progenitor cells, their migration and proliferation, the formation of the ventricular chamber, and the establishment of its distinct morphological and functional identity. The process is distinct from left ventricle morphogenesis and involves unique genetic programs and cellular behaviors.
Why Is cardiac right ventricle morphogenesis Important in Cell Biology?
Cardiac right ventricle morphogenesis is fundamental for establishing a functional heart capable of supporting pulmonary circulation. Defects in this process result in severe congenital heart malformations, such as hypoplastic right heart syndrome and ventricular septal defects, which require surgical intervention and can lead to lifelong morbidity. Understanding the genetic and cellular mechanisms of right ventricle development is therefore critical for diagnosing, preventing, and treating these conditions. Moreover, insights into right ventricle morphogenesis inform regenerative medicine approaches aimed at repairing damaged myocardium, as the right ventricle has distinct developmental origins and regenerative capacities compared to the left ventricle.
• Congenital heart defects affecting the right ventricle are among the most common birth defects.
• Right ventricle morphogenesis is evolutionarily conserved but has unique features across species.
• Disruption of transcription factor networks (e.g., HEY2, TBX2) leads to right ventricular hypoplasia.
• The right ventricle is derived from distinct progenitor populations, offering targets for regenerative therapies.
• Injury-responsive programs, such as GATA4 activation, can modulate ventricular regeneration.
• Spatial organization of cell types in the developing heart informs tissue engineering strategies.
• Angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 supports right ventricle growth.
• Zebrafish models enable high-throughput genetic screens for right ventricle morphogenesis.
• Understanding right ventricle development aids in interpreting variants of uncertain significance in CHD genes.
• CRISPR screening can identify novel regulators of right ventricle morphogenesis.
What Happens During cardiac right ventricle morphogenesis?
Specification of right ventricular progenitors
In simple terms: Certain early embryonic cells are told to become the right ventricle.
The right ventricle originates from progenitor cells in the anterior/second heart field, which are distinct from those forming the left ventricle. These progenitors are marked by the expression of specific genes, and their specification depends on signaling pathways such as FGF and BMP. For example, Sfrp5-negative progenitors contribute to all myocardial structures except the right ventricle, highlighting the existence of dedicated right ventricular progenitors. The transcription factor HEY2 plays a crucial role in right ventricle development by regulating the Tbx2-Mycn pathway.
Migration and addition to the heart tube
In simple terms: The right ventricle cells move to the growing heart and attach to it.
After specification, right ventricular progenitors migrate and are added to the arterial pole of the linear heart tube. This process is regulated by complex tissue interactions and is essential for the elongation and looping of the heart tube. Disruption of this addition leads to a shortened outflow tract and right ventricular hypoplasia. The transcription factor TBX2 is involved in repressing chamber-specific genes in the outflow tract, and its dysregulation affects right ventricle morphogenesis.
Chamber formation and trabeculation
In simple terms: The right ventricle takes shape and develops its inner sponge-like structure.
Once the right ventricular progenitors are in place, they proliferate and differentiate into cardiomyocytes, forming the ventricular chamber. Trabeculation, the formation of muscular ridges, is a key step that increases the surface area for blood oxygenation and is regulated by Notch signaling and other pathways. The transcription factor MYCN is essential for cardiomyocyte proliferation and right ventricle growth, and its expression is controlled by HEY2 and TBX2. GATA4, an injury-responsive factor, can also influence ventricular remodeling.
Coronary angiogenesis and maturation
In simple terms: Blood vessels grow into the right ventricle to supply it with oxygen and nutrients.
As the right ventricle grows, it requires a dedicated blood supply. Coronary vessels form via angiogenesis from pre-existing vessels, a process dependent on DLL4-NOTCH1 signaling. This angiogenic process is critical for right ventricular maturation and function. Defects in coronary development can lead to myocardial hypoxia and impaired right ventricle morphogenesis.
Spatial organization of cellular communities
In simple terms: Different cell types arrange themselves in specific patterns to build the right ventricle.
Recent spatial transcriptomics studies have revealed that the developing human heart, including the right ventricle, is composed of spatially organized cellular communities. These communities consist of cardiomyocytes, fibroblasts, endothelial cells, and other cell types that interact to coordinate morphogenesis. Disruption of these spatial relationships can lead to congenital heart defects.
Key Genes Involved in GO:0003215 cardiac right ventricle morphogenesis
The following genes have been experimentally implicated in cardiac right ventricle morphogenesis, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HEY2 | Transcription factor regulating Tbx2-Mycn pathway | Knockout leads to right ventricle hypoplasia |
| TBX2 | Represses chamber-specific genes in outflow tract | Regulates right ventricle identity |
| MYCN | Promotes cardiomyocyte proliferation | Essential for right ventricle growth |
| GATA4 | Injury-responsive transcription factor | Modulates ventricular regeneration |
| SFRP5 | Marks progenitors excluding right ventricle | Lineage tracing of right ventricle progenitors |
| DLL4 | Notch ligand in angiogenesis | Coronary vessel development for right ventricle |
| NOTCH1 | Receptor for DLL4 | Angiogenesis and right ventricle maturation |
| NKX2-5 | Cardiac transcription factor | Early heart development, including right ventricle |
| TBX5 | Transcription factor | Chamber identity and septation |
| MEF2C | Transcription factor | Cardiomyocyte differentiation |
| HAND2 | Transcription factor | Right ventricle development |
| ISL1 | Progenitor marker | Second heart field progenitors |
| FGF8 | Signaling molecule | Pharyngeal mesoderm patterning |
| BMP4 | Signaling molecule | Heart field specification |
| VEGFA | Angiogenic factor | Coronary development |
| CDH5 | Endothelial marker | Coronary angiogenesis |
| ACTC1 | Cardiac actin | Sarcomere formation |
How Is cardiac right ventricle morphogenesis Regulated?
The process of cardiac right ventricle morphogenesis is regulated by a complex network of transcription factors, signaling pathways, and epigenetic modifiers. Key regulatory nodes include the HEY2-TBX2-MYCN axis, which controls cardiomyocyte proliferation and chamber identity. Notch signaling, via DLL4-NOTCH1, regulates coronary angiogenesis and right ventricle maturation. Additionally, injury-responsive programs such as GATA4 activation can modulate ventricular remodeling and regeneration. Spatial organization of cellular communities, as revealed by single-cell and spatial transcriptomics, adds another layer of regulation, ensuring proper tissue architecture.
cardiac right ventricle morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HEY2 | Hypoplastic right heart syndrome | Knockout mouse, zebrafish |
| TBX2 | Ventricular septal defects | Knockout mouse |
| MYCN | Right ventricular hypoplasia | Conditional knockout mouse |
| GATA4 | Congenital heart defects | Zebrafish injury model |
| DLL4 | Coronary artery anomalies | Endothelial-specific knockout mouse |
Congenital heart defects
Disruptions in cardiac right ventricle morphogenesis are a major cause of congenital heart defects (CHDs), including hypoplastic right heart syndrome, pulmonary atresia, and ventricular septal defects. Mutations in genes such as HEY2, TBX2, and MYCN have been associated with right ventricular hypoplasia in animal models. Understanding these genetic causes can improve diagnosis and genetic counseling for affected families.
Right ventricular failure
Acquired conditions such as pulmonary hypertension and myocardial infarction can lead to right ventricular failure. While not directly caused by developmental defects, the molecular pathways involved in right ventricle morphogenesis, such as angiogenesis and cardiomyocyte proliferation, may be reactivated or dysregulated in disease. Studying developmental mechanisms can inform therapeutic strategies for right ventricular failure.
Regenerative medicine
The right ventricle has been shown to possess some regenerative capacity in animal models, partly mediated by injury-responsive factors like GATA4. Harnessing these developmental programs could lead to novel therapies for heart repair. CRISPR-based models are instrumental in dissecting the regenerative mechanisms specific to the right ventricle.
From cardiac right ventricle morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate right ventricle morphogenesis? | Knockout zebrafish or mouse |
| What is the effect of a specific point mutation in gene Y? | Point mutation knock-in mouse |
| How does gene Z overexpression affect right ventricle size? | Overexpression transgenic zebrafish |
| Where is protein X expressed during right ventricle development? | Tagged knock-in reporter mouse |
| What are the downstream targets of transcription factor HEY2? | RNA-seq after knockout |
| Can CRISPR screening identify novel right ventricle regulators? | Pooled CRISPR screen in zebrafish |
How to Study the cardiac right ventricle morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Gene expression at single-cell level | Identify cell types in developing right ventricle |
| Spatial transcriptomics | Gene expression with spatial context | Map cellular communities in heart |
| CRISPR knockout | Gene function loss | Test candidate genes for right ventricle morphogenesis |
| CRISPR knock-in | Tagged or mutant protein expression | Track protein localization or model point mutations |
| Zebrafish video tracking | Cardiac rhythm and function | High-throughput phenotyping of mutants |
| Lineage tracing | Progenitor cell fate | Determine origin of right ventricular cells |
| Immunohistochemistry | Protein localization | Validate expression patterns |
| RNA-seq | Transcriptome-wide expression | Identify downstream targets of transcription factors |
Lineage tracing and genetic fate mapping
Lineage tracing using Cre-lox or CRISPR-based reporters allows researchers to follow the fate of right ventricular progenitors. For example, Sfrp5 lineage tracing revealed that Sfrp5-negative progenitors contribute to all myocardial structures except the right ventricle. This method is essential for understanding the origin of right ventricular cells.
Single-cell and spatial transcriptomics
Single-cell RNA sequencing and spatial transcriptomics have been used to map the cellular composition and spatial organization of the developing human heart, including the right ventricle. These techniques identify distinct cell types and their interactions, providing insights into morphogenetic mechanisms.
Zebrafish cardiac imaging and functional assays
Zebrafish embryos are transparent, allowing real-time imaging of heart development. Automated cardiac rhythm measurement using OpenCV-based approaches enables high-throughput analysis of heart function in zebrafish models. This is particularly useful for studying right ventricle morphogenesis mutants.
CRISPR/Cas9 genome editing
CRISPR/Cas9 enables precise knockout, knock-in, and point mutations in genes suspected to regulate right ventricle morphogenesis. For example, knockout of Hey2 in mice demonstrated its role in right ventricle development through the Tbx2-Mycn pathway. CRISPR screens can also identify novel regulators in an unbiased manner.
How CRISPR Can Be Used to Study GO:0003215 cardiac right ventricle morphogenesis
Knockout
CRISPR knockout is used to completely ablate genes suspected to be involved in right ventricle morphogenesis. For example, knockout of Hey2 in mice led to right ventricular hypoplasia, demonstrating its essential role. Knockout models help establish causality between gene loss and developmental defects.
Point Mutation
Point mutations can be introduced via CRISPR to model specific human variants associated with congenital heart defects. This allows researchers to study the functional impact of missense mutations in genes like TBX2 or MYCN without completely abolishing protein function.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or human disease alleles enables visualization and functional analysis of proteins in the developing right ventricle. Tagged knock-in models are valuable for lineage tracing and protein localization studies.
Overexpression
CRISPR activation (CRISPRa) or transgenic overexpression can be used to study the effects of increased gene dosage. Overexpression of factors like GATA4 may enhance regenerative responses in the right ventricle. This approach helps identify sufficiency of a gene to drive morphogenetic processes.
How EDITGENE Supports cardiac right ventricle morphogenesis Research
Researchers studying cardiac right ventricle morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. This requires precise genetic manipulation in model systems, which is where EDITGENE's CRISPR services can accelerate discovery.
Contact EDITGENE today to design your custom CRISPR model for cardiac right ventricle morphogenesis research.
Frequently Asked Questions About cardiac right ventricle morphogenesis
What is cardiac right ventricle morphogenesis?
Cardiac right ventricle morphogenesis (GO:0003215) is the biological process by which the right cardiac ventricle is generated and organized during embryonic development.
What genes are involved in cardiac right ventricle morphogenesis?
Key genes include HEY2, TBX2, MYCN, GATA4, SFRP5, DLL4, and NOTCH1, among others.
What diseases are associated with defects in right ventricle morphogenesis?
Defects can lead to congenital heart defects such as hypoplastic right heart syndrome, pulmonary atresia, and ventricular septal defects.
How is the right ventricle formed during embryogenesis?
The right ventricle originates from anterior/second heart field progenitors that migrate to the heart tube, proliferate, and differentiate into cardiomyocytes, followed by trabeculation and coronary angiogenesis.
What is the role of HEY2 in right ventricle development?
HEY2 is a transcription factor that regulates the Tbx2-Mycn pathway, controlling cardiomyocyte proliferation and right ventricle morphogenesis.
What animal models are used to study right ventricle morphogenesis?
Zebrafish, mice, and chick embryos are commonly used, with zebrafish offering advantages for high-throughput imaging and genetic screens.
How can CRISPR be used to study right ventricle morphogenesis?
CRISPR enables knockout, knock-in, point mutation, and overexpression of candidate genes in model organisms and cell lines to test their function.
What is the difference between right and left ventricle morphogenesis?
The right ventricle derives from distinct progenitor populations and has unique gene expression programs, such as dependence on HEY2 and TBX2, compared to the left ventricle.
What signaling pathways regulate right ventricle morphogenesis?
Key pathways include Notch (DLL4-NOTCH1), FGF, BMP, and retinoic acid signaling, which control progenitor specification, proliferation, and differentiation.
How does GATA4 influence right ventricle development?
GATA4 is an injury-responsive transcription factor that can modulate ventricular remodeling and regeneration, and its dysregulation is linked to congenital heart defects.
Conclusion
Cardiac right ventricle morphogenesis (GO:0003215) is a complex developmental process essential for heart function. Research over the past decades has identified critical genes and pathways, yet many questions remain. Advances in CRISPR genome editing, single-cell omics, and spatial transcriptomics are poised to accelerate discovery. Understanding this process not only sheds light on congenital heart disease but also informs regenerative strategies for right ventricular failure.
References
- 1. Farah EN et al.. 2024. Spatially organized cellular communities form the developing human heart.. Nature 627(8005):854-864 PMID: 38480880
- 2. Seya D et al.. 2021. A role of Hey2 transcription factor for right ventricle development through regulation of Tbx2-Mycn pathway during cardiac morphogenesis.. Dev Growth Differ 63(1):82-92 PMID: 33410138
- 3. Farhan A et al.. 2021. An OpenCV-Based Approach for Automated Cardiac Rhythm Measurement in Zebrafish from Video Datasets.. Biomolecules 11(10) PMID: 34680109
- 4. Albu M et al.. 2024. Distinct mechanisms regulate ventricular and atrial chamber wall formation.. Nat Commun 15(1):8159 PMID: 39289341
- 5. Kelly RG. 2007. Building the right ventricle.. Circ Res 100(7):943-5 PMID: 17431196
- 6. Gupta V et al.. 2013. An injury-responsive gata4 program shapes the zebrafish cardiac ventricle.. Curr Biol 23(13):1221-7 PMID: 23791730
- 7. Lu P et al.. 2021. Perinatal angiogenesis from pre-existing coronary vessels via DLL4-NOTCH1 signalling.. Nat Cell Biol 23(9):967-977 PMID: 34497373
- 8. Fujii M et al.. 2017. Sfrp5 identifies murine cardiac progenitors for all myocardial structures except for the right ventricle.. Nat Commun 8:14664 PMID: 28287088
